InvestorsHub Logo

guardiangel

10/20/14 6:11 PM

#25699 RE: guardiangel #25698

DC Here is a crumb for you..One more step to Radient's revival Amen Wolf ahooooololooooooooo

When we pointed out that the test was only allowed in 26 states..They took the states icon off..Now it appears the 19 year old former CEO of Mac's shell typed the 25 states and the District of Columbia..Now you need to add one more state you understand...

http://globalcancerdx.com/Order.html

GetSeriousOK

10/20/14 6:39 PM

#25700 RE: guardiangel #25698

What lake? ands what "documentations?"

All the documentation I find says very clearly that LC Sentinel was Radient's reagents and nothing more. Here's my documentation -- please post yours and let's compare.

http://www.marketwired.com/press-release/radient-pharmaceuticals-provista-life-sciences-announce-new-blood-test-lung-cancer-nyse-amex-rpc-1334094.htm

"The study completed the requisite analyses and data evaluation needed to validate Provista's test, based on Radient Pharmaceutical Corporation's antigens for fibrinogen degradation products (FDP), successfully detects lung cancer with a high degree of accuracy."

That means DR-70, detection of fibrin and fibrinogen. Provista's test was nothing more.

"The study included men and women between 20-76 years of age. The data generated in this final study proved consistent with previous findings and produced positive clinical performance marks of 87% sensitivity; 95% specificity; and an ROC Accuracy of 0.97. "

Sound familiar? Gartner is using these numbers to pitch his lung cancer test to investors. His test is also DR-70 and nothing more.

As for Provista's breast cancer test -- the main selling point is that this test is specific to breast cancer. If Provista added "Radient reagents and biomarkers" to the test it would no longer be specific to breast cancer. That alone is proof enough for me that Provista's test does not use Radient's reagents.

But the irrefutable proof will be when Provista releases the abstract for their latest trials. That will tell whether their breast cancer test detects fibrin and/or fibrinogen. I look forward to the release of that abstract.